Conclusion Of Non-exclusive Drug Discount Agreements According To § 130a Para. 8 Sgb V By Way Of A So-called Open-house Model For The Active Ingredient Dornase Alfa (atc Code According To Who: R05cb13

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 10625039

  Document Type - Tender Notices

Description - Contract notice: Conclusion of non-exclusive drug discount agreements according to § 130a para. 8 sgb v by way of a so-called open-house model for the active ingredient dornase alfa (atc code according to who: r05cb13)The subject of this publication is the conclusion of non-exclusive discount agreements according to § 130a para. 8 sgb v on medicinal products with the active ingredient dornase alfa (atc code according to who: r05cb13). the contract is concluded as part of a so-called open-house model, i. H. A contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. As a result, individual contr

Gt Ref Id - 10625039

Deadline - Mar 31, 2025